Roberto Padoan - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Roberto Padoan

Showing results (71-80 of 73) with videos related to

Pageof 8

Sort By:

You have reached the last page of results.This site can display upto 73 results.

The Lancet. Rheumatology|January 22, 2024

Benralizumab for eosinophilic granulomatosis with polyangiitis: a retrospective, multicentre, cohort studyAlessandra Bettiol, Maria Letizia Urban, Roberto Padoan, et al.

Journal of Autoimmunity|March 27, 2025

Mepolizumab versus benralizumab for eosinophilic granulomatosis with polyangiitis (EGPA): A European real-life retrospective comparative studyIrene Mattioli, Maria Letizia Urban, Roberto Padoan, et al.

The European Respiratory Journal|April 9, 2021

Risk of acute arterial and venous thromboembolic events in eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome)Alessandra Bettiol, Renato Alberto Sinico, Franco Schiavon, et al.

Pageof 8

Search research articles

Showing results (71-80 of 73) with videos related to

Sort By:

Pageof 8

You have reached the last page of results.This site can display upto 73 results.

The Lancet. Rheumatology|January 22, 2024

Benralizumab for eosinophilic granulomatosis with polyangiitis: a retrospective, multicentre, cohort studyAlessandra Bettiol, Maria Letizia Urban, Roberto Padoan, et al.

Journal of Autoimmunity|March 27, 2025

The European Respiratory Journal|April 9, 2021

Risk of acute arterial and venous thromboembolic events in eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome)Alessandra Bettiol, Renato Alberto Sinico, Franco Schiavon, et al.

Pageof 8